Propio

Escors Murugarren

David
‘Development of new immunotherapies against cancer’
David Escors Murugarren

World's Top 2% Scientists (Stanford University)

Dr. David Escors Murugarren is a Spanish researcher born in Pamplona, Navarre, in 1974. He earned a degree in Biological Sciences from the University of Navarre and completed his doctoral thesis at the Autonomous University of Madrid in 2002. His thesis focused on the structure of the coronavirus of transmissible porcine gastroenteritis and the encapsidation of its genome. After completing his doctorate, he continued his postdoctoral training as a Marie Curie researcher at University College London (UCL), where he collaborated on research about lentiviral vectors and their use in cancer immunotherapy. In 2013, he returned to Spain and joined the Navarrabiomed Research Center, where he leads the immunomodulation group. Dr. Escors specializes in oncological immunotherapy and has published more than one hundred articles, reviews, and book chapters. His research focuses on the development of new immunotherapies for solid tumors, and he has been awarded the V SER Navarra Award (Innovation Category) for his work in research on the

SARS-CoV-22.
(me dice copilot que a ver si no es : SARS-CoV-2) 
 

Área de investigación
Unidad o grupo de investigación
Tipo de investigador
Navarrabiomed
Tipo de investigación
Unidad de investigación
Tesis dirigidas defendidas
María Gato Cañas
Study of two barriers in melanoma immunotherapy: Myeloid derived suppressor cells and PDL1/PD1 interaction.
Alessio Lanna
Molecular Tuning of Telomerase Activity in Senescent Human T cells.
Christopher Bricogne
Plasma membrane dynamics regulating the PD-1: PD-L1 pathway.
Therese Maria Liechtenstein
Lentivector-based cancer immunotherapy silencing PD-L1 and modulating cytokine priming; Development of ex vivo myeloid-derived suppressor cells to assess therapeutic efficacy.
Mehdi Baratchian
Understanding the mechanisms of NF-kB activation by viral oncoproteins vFLIP and Tax.
Holly Nicole Stephenson
Innate Immune Recognition of Glycosylated Surface Determinants of Campylobacter jejuni.

Albéniz Arbizu

Eduardo
Advancing non-invasive early diagnosis
Eduardo Albéniz Arbizu

Eduardo Albéniz holds a medical degree (Medicine and Surgery) from the University of Navarra (1998) and specialized in Digestive System (MIR) at Ramón y Cajal Hospital in Madrid (1999-2003). Professionally, he has worked at HU Angers-France (2003), Hospital San Rafael in Madrid (2003-2004), and Complejo Hospitalario Universitario de Albacete (2004-2009). Since 2009, he has worked as a Consultant Gastroenterologist in the Endoscopy Unit of the Digestive System Service at the University Hospital of Navarra (HUN). Furthermore, since 2018 he combines his clinical activity with research thanks to several fellowships for Intensification (50% research activity; 50% clinical activity). These fellowships enabled him to complete his PhD in Medicine at the Public University of Navarra in 2021.


Dr. Albéniz has coordinated since 2013 the national Endoscopic Resection group of the Spanish Society of Digestive Endoscopy (SEED), whose main work is to promote national and international collaborative research in this field.
 
Since 2023, he has been a Member of the Board of Directors and Chair of the society´s scientific Committee. In addition, he coordinates the research activity of the Digestive System Service, the Resection and treatment unit for digestive motor disorders, and the CSUR functional unit for achalasia of the HUN.

Throughout his career, he has been a tutor for residents and, currently, he is directing 3 doctoral theses. He has participated in 38 research projects, 22 of them as PI and 10 of them awarded with competitive funding (SEED, ESGE, SVNPD, MEDTECH Navarra and ISCIII). He has also collaborated in the development of the European ESGE (European Society of Gastrointestinal Endoscopy) guidelines on Endoscopic Mucosal Resection and on training in POEM (Per-Oral Endoscopy Miotomy). As a result of this work, Dr. Albéniz is the author of more than 90 scientific publications in journals with a high impact index.
 

Área de investigación
Unidad o grupo de investigación
Tipo de investigador
Navarrabiomed
Tipo de investigación
Unidad de investigación